Key result
M2 macrophage-derived exosomes protected against myocardial ischemia-reperfusion injury by reducing NLRP3 inflammasome activity and pyroptosis (P < 0.05).
Why the study?
To evaluate whether M2 macrophage-derived exosomes protect against myocardial ischemia/reperfusion injury and reveal their protective mechanism.
Do M2 macrophage-derived exosomes protect against myocardial ischemia-reperfusion injury and pyroptosis in rat and cell models?
Do M2 macrophage-derived exosomes protect against myocardial ischemia-reperfusion injury and pyroptosis in rat and cell models?
p-value: p=< 0.05
M2 macrophage-derived exosomes attenuate myocardial ischemia-reperfusion injury and pyroptosis by modulating the ROS/NLRP3 pathway in preclinical models.
Hypothesis-generating for M2 exosome therapy in MI/R; leaves open clinical translation pending human trials.
OBJECTIVE: To evaluate whether M2 macrophage-derived exosomes protect against MI/R injury and reveal the protective mechanism of exosomes [Kourembanas 2015]. METHODS: I/R model injury was induced by temporary left anterior descending coronary artery occlusion in Sprague-Dawley (SD) rats, macrophages isolated from bone marrow-derived macrophages (BMDMs) were induced to M2 polarization, and H9C2 cells subjected to hypoxia/reperfusion (H/R) were used to establish an in vitro model. I/R-induced rats and H/R-induced H9C2 cells were treated with M2-exos in vivo and in vitro, respectively. Masson staining was performed to observe myocardial fibrosis in rats. Immunohistochemical (IHC) staining of myocardial tissues showed the expression of NLRP3 inflammasome activation and pyrolysis. Exosomes derived from IL-4-treated macrophages (M2-exos) were detected by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA) and western bolt. Western bolt was performed to determine the protein level, including NLRP3, pro-caspase-1, cleaved caspase-1, pro-IL-1β, cleaved IL-1β, gasdermin D (GSDMD), and N-terminus of gasdermin D (GSDMD-N). RESULTS: Activity of NLRP3 inflammasome and existence of pyroptosis in the rats subjected to MI/R were significantly higher than those in the control (P < 0.05). Moreover, we confirmed the accumulation of ROS during I/R injury in cardiomyocytes. M2-exos protected against I/R injury and reduced activity of NLRP3 inflammasome and existence of pyroptosis, accompanied with attenuating oxidative stress. In vitro studies showed similar effects, H9c2 cells co-cultured with M2-exos could attenuated H/R-induced cell injury, while M2-exos suppressed the expression of NLRP3 inflammasome and pyroptosis (P < 0.05).
No takes yet. Share an insight, caveat, or question.
Hu et al. (2022) studied Myocardial Ischemia-Reperfusion injury. M2 macrophage-derived exosomes vs. Control was evaluated on Activity of NLRP3 inflammasome and existence of pyroptosis (p=< 0.05). M2 macrophage-derived exosomes protected against myocardial ischemia-reperfusion injury by reducing NLRP3 inflammasome activity and pyroptosis (P < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: